In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature

Biomed Pharmacother. 2019 Jan:109:1085-1099. doi: 10.1016/j.biopha.2018.10.130. Epub 2018 Nov 6.

Abstract

Quercetin, a typical flavonoid, possesses diverse biochemical and physiological actions, including antiplatelet, estrogenic, and anti-inflammatory properties. This review mainly centers on recent ten years findings with respect to intervening diabetes and its complications with the well-known flavonoid quercetin. After a short introduction of quercetin, major in vitro and in vivo findings are summarized showing that quercetin is a promising molecule for the treatment of these diseases. Finally, we contemplate future development and application prospects of quercetin. Despite the wealth of in animal research results suggesting the anti-diabetic and its complications potential of quercetin, its efficacy in diabetic human subjects is yet to be explored. The problem may become an important direction in the future research.

Keywords: Diabetes; Diabetic complications; In vitro and in vivo evidence; Quercetin.

Publication types

  • Systematic Review

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Diabetes Complications / drug therapy*
  • Diabetes Mellitus / drug therapy*
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Humans
  • Protective Agents / pharmacology*
  • Protective Agents / therapeutic use*
  • Quercetin / pharmacology*
  • Quercetin / therapeutic use*

Substances

  • Antioxidants
  • Flavonoids
  • Protective Agents
  • Quercetin